Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Atos homolog protein A (ATOSA) is a conserved transcription regulator found in mammals and other vertebrates, encoded by the human FAM214A gene (also known as KIAA1370, FLJ10980)[3][7]. It contains transactivation domains that may be required for transcriptional activation of specific target genes[1]. The protein is predicted to localize to the nucleus and regulate transcription and translation, particularly in coordination for macrophage tissue invasion[3][5][7][8][13]. In model organisms (e.g., Drosophila), its homolog is implicated in controlling cellular metabolism, but the precise molecular functions in humans and disease relevance remain insufficiently characterized[8]. There is some evidence of expression in cancer cell lines, but no established drug interactions, clinical biomarkers, or direct therapeutic targeting have been reported[9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Atos homolog protein A (ATOSA).